Rigel Pharmaceuticals, Inc. (RIGL)
Market Closed
10 Sep, 20:00
$
47. 28
+0.06
+0.1271%
Pre Market
$
+0.32 +0.6768% 47. 60
900.5M Market Cap
- P/E Ratio
- Div Yield
130,856 Volume
-0.06 Eps
$ 47.22
Previous Close 
Want to track RIGL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rigel Pharmaceuticals, Inc. (RIGL) Statistics
Valuation metrics
Market Cap 900.5M
Enterprise value 879.63M
Trailing P/E (ttm) 2.75
Forward P/E 6.33
PEG ratio 0.01
Price/Sales (ttm) 3.25
Price/Book (mrq) 2.12
Enterprise Value/Revenue 3.18
Enterprise Value/EBITDA 9.35
Overview
Shares outstanding 18.48M
Float 15.95M
Shares short 3.94M
% Held by insiders 0.03%
% Held by institutions 0.94%
Average volume (10 days) 79K
Average volume (90 days) 260.26K
Price summary
52-Week low 24.95
52-Week high 52.24
Beta 1.2
50-Day moving average 41.16
200-Day moving average 30.76
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 27 Jun 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 1.16%
Operating margin 0.31%
Operational effectiveness
Return on assets 0.62%
Return on equity 0.96%
Income Statement
Revenue (ttm) 299.77M
Revenue per share (ttm) 14.93
Quarterly revenue growth (yoy) 0.1%
Gross profit (ttm) 243.41M
EBITDA 131.28M
Net income to common (ttm) 364.23M
Diluted EPS (ttm) 17.36
Quarterly earnings growth (yoy) -0.24%
Balance Sheet
Total cash (mrq) 146.68M
Total cash per share (mrq) 5.14
Total debt (mrq) 45.72M
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 1.95%
Book value per share (mrq) 22.96
Cash Flow
Cash flow statement 79.27M
Levered free cash flow (LFCF) 78.55M
